Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar, +614

The Lancet Neurology

Multicentre StudyPharmacologyMedicineMyasthenia GravisNeuromuscular Blockade +1

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi, +562

Neurology

Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study

Yuriko Nagane, Hiroyuki Murai, Tomihiro Imai, +12

BMJ Open

Changes in inflammatory cytokine networks in myasthenia gravis

Akiyuki Uzawa, Tetsuya Kanai, Naoki Kawaguchi, +3

Scientific Reports

ImmunologyImmune RegulationPathologyImmunotherapyCellular Physiology +14

A clinical predictive score for postoperative myasthenic crisis

Tetsuya Kanai, Akiyuki Uzawa, Yasunori Sato, +20

Annals of Neurology

Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis

Tetsuya Kanai, Akiyuki Uzawa, Naoki Kawaguchi, +4

Journal of the Neurological Sciences

Predictive ScoreNeurologyGlucocorticoidMedicineMyasthenia Gravis

Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis

Akiyuki Uzawa, Naoki Kawaguchi, Tetsuya Kanai, +5

Journal of Neurology

SurgeryThyroid HormoneTwo-year Outcome

HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients

Tetsuya Kanai, Akiyuki Uzawa, Naoki Kawaguchi, +5

Journal of the Neurological Sciences

Autoimmune DiseaseImmunologyPathologyAutoimmunityAutoantibodies +6

Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis

Yukiko Ozawa, Akiyuki Uzawa, Tetsuya Kanai, +5

Journal of the Neurological Sciences

Ocular DiseaseOphthalmologyGlaucomaDermatologyOcular Pathology +2

Serum high mobility group box 1 is upregulated in myasthenia gravis

Akiyuki Uzawa, Naoki Kawaguchi, Tetsuya Kanai, +2

Journal of Neurology Neurosurgery & Psychiatry